Rigel Pharmaceuticals Inc (RIGL)
Depreciation & Amortization
$2.65M
TTM · Period ending: · USD
RIGL Depreciation & Amortization
Latest reported$2.65Mperiod ending
Latest reported$2.65Mperiod ending
RIGL TTM Depreciation & Amortization ($6.76M → $2.65M)
TTM Depreciation & Amortization
High-resolution chart · PNG
RIGL depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 2,649,000 | |
| 2,408,000 | |
| 2,415,000 | |
| 2,418,000 | |
| 2,426,000 | |
| 2,432,000 | |
| 2,228,000 | |
| 1,917,000 | |
| 1,598,000 | |
| 1,281,000 | |
| 1,238,000 | |
| 1,229,000 | |
| 1,177,000 | |
| 1,118,000 | |
| 998,000 | |
| 1,118,000 | |
| 1,139,000 | |
| 1,160,000 | |
| 1,162,000 | |
| 964,000 | |
| 868,000 | |
| 774,000 | |
| 706,000 | |
| 680,000 | |
| 681,000 | |
| 690,000 | |
| 683,000 | |
| 666,000 | |
| 659,000 | |
| 645,000 | |
| 594,000 | |
| 544,000 | |
| 497,000 | |
| 452,000 | |
| 465,000 | |
| 495,000 | |
| 597,000 | |
| 743,000 | |
| 941,000 | |
| 1,136,000 | |
| 1,209,000 | |
| 1,328,000 | |
| 1,439,000 | |
| 1,608,000 | |
| 1,895,000 | |
| 2,139,000 | |
| 2,359,000 | |
| 2,503,000 | |
| 2,573,000 | |
| 2,578,000 | |
| 2,592,000 | |
| 2,577,000 | |
| 2,568,000 | |
| 2,550,000 | |
| 2,433,000 | |
| 2,323,000 | |
| 2,194,000 | |
| 2,060,000 | |
| 1,955,000 | |
| 1,822,000 | |
| 1,643,000 | |
| 1,459,000 | |
| 1,317,000 | |
| 1,270,000 | |
| 1,308,000 | |
| 1,388,000 | |
| 1,403,000 | |
| 1,418,000 | |
| 1,407,000 | |
| 1,403,000 | |
| 1,425,000 | |
| 1,399,000 | |
| 1,380,000 | |
| 1,350,000 | |
| 1,344,000 | |
| 1,438,000 | |
| 1,428,000 | |
| 1,420,000 | |
| 1,418,000 | |
| 1,469,000 | |
| 1,257,000 | |
| 1,203,000 | |
| 1,180,000 | |
| 1,418,000 | |
| 1,796,000 | |
| 2,057,000 | |
| 2,373,000 | |
| 2,307,000 | |
| 2,515,000 | |
| 2,801,000 | |
| 3,177,000 | |
| 3,901,000 | |
| 4,463,000 | |
| 5,105,000 | |
| 5,824,000 | |
| 6,181,000 | |
| 6,554,000 | |
| 6,576,000 | |
| 6,760,000 |